Clinical Trials · NCT07781371

A Retrospective Real-World Cohort Study

Active Not RecruitingN/ASemaglutide (Investigational)
Phase
N/A
Recruitment status
Active Not Recruiting
Sponsor
Novo Nordisk A/S
Enrollment
100,000
Start date
Aug 2026
Locations
1 site, Denmark
Primary endpoint
Index and yearly prevalence of major cardiometabolic diseases (percentage)
View Semaglutide compound reference